Royal Bank of Canada’s Moderna MRNA Stock Holding History

Royal Bank of Canada’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Buy	38,500 +37,300	+3,108%	+$1.74M	﹤0.01%	3116
2025 Q4	$35K	Buy	+1,200	New	+$32.6K	﹤0.01%	5739
2025 Q3	–	Sell	-1,200	Closed	-$33K	–	7362
2025 Q2	$33K	Hold	1,200	–	–	﹤0.01%	6087
2025 Q1	$34K	Hold	1,200	–	–	﹤0.01%	5720
2024 Q4	$50K	Buy	+1,200	New	+$57.4K	﹤0.01%	5698
2023 Q3	–	Sell	-1,900	Closed	-$231K	–	7381
2023 Q2	$231K	Buy	+1,900	New	+$253K	﹤0.01%	4606
2023 Q1	–	Sell	-28,000	Closed	-$5.03M	–	7324
2022 Q4	$5.03M	Sell	28,000 -8,000	-22%	-$1.31M	﹤0.01%	2144
2022 Q3	$4.26M	Hold	36,000	–	–	﹤0.01%	2202
2022 Q2	$5.14M	Hold	36,000	–	–	﹤0.01%	2072
2022 Q1	$6.2M	Sell	36,000 -100,000	-74%	-$16.8M	﹤0.01%	2075
2021 Q4	$34.5M	Buy	136,000 +98,700	+265%	+$28.9M	0.01%	1042
2021 Q3	$14.4M	Sell	37,300 -700	-2%	-$258K	﹤0.01%	1571
2021 Q2	$8.93M	Buy	+38,000	New	+$6.79M	﹤0.01%	1888
2021 Q1	–	Sell	-54,600	Closed	-$5.7M	–	7594
2020 Q4	$5.7M	Buy	+54,600	New	+$5.52M	﹤0.01%	2111

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's MRNA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Moderna (MRNA) stake by 13% in Q1 2026, selling an estimated $6.74M and leaving 999,340 shares worth $50.8M. The position accounts for 0.01% of the portfolio, ranked #908.

Royal Bank of Canada first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $171M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Royal Bank of Canada held 999,340 shares of Moderna worth $50.8M as of Q1 2026.
Royal Bank of Canada sold 144,440 Moderna shares in Q1 2026, an estimated $6.74M.
Moderna made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #908 holding.
Royal Bank of Canada first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
Royal Bank of Canada's Moderna position peaked at $171M in Q4 2021.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.